FASLG / CD178 Molecule
Fas Ligand Molecule Synonym Name
Fas Ligand Protein Products
|Cat No||Species||Product Description|
|FAG-H9241||Human||C13 and N15-labeled, Human Fas Ligand / TNFSF6 Protein|
|FAL-H5241||Human||Human Fas Ligand / TNFSF6 Protein|
Fas Ligand Molecule Background
Fas ligand is also known as FasL, CD178, CD95L, or TNFSF6, is a homotrimeric type-II transmembrane protein that belongs to the tumor necrosis factor (TNF) family. Its binding with its receptor induces apoptosis. Fas ligand/receptor interactions play an important role in the regulation of the immune system and the progression of cancer. Mature human Fas Ligand consists of a 179 amino acid (aa) extracellular domain (ECD), a 22 aa transmembrane segment, and a 80 aa cytoplasmic domain. Within the ECD, human Fas Ligand shares 81% and 78% aa sequence identity with mouse and rat Fas Ligand, respectively. Apoptosis triggered by Fas-Fas ligand binding plays a fundamental role in the regulation of the immune system. Its functions include:T-cell homeostasis, cytotoxic T-cell activity, immune privilege, maternal tolerance, tumor counterattack. Defective Fas-mediated apoptosis may lead to oncogenesis as well as drug resistance in existing tumors. Germline mutation of Fas is associated with autoimmune lymphoproliferative syndrome (ALPS), a childhood disorder of apoptosis.
- (1) Sheikh MS, Fornace AJ., 2000, Leukemia 14 (8): 1509–1513.
- (2) Andersen MH, et al., 2006, J. Invest. Dermatol. 126 (1): 32–41.
- (3) Igney FH, Krammer PH., 2005, Cancer Immunol. Immunother. 54 (11): 1127–1136.